Top Markets
Coin of the day
Eli Lilly Eli Lilly

Eli Lilly

LLY
Pozycja w akcjach #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Cena akcji
$910.55
Kapitalizacja rynkowa
$860.30B
Zmiana (1 dzień)
0.44%
Zmiana (1 rok)
5.28%
Kraj
US
Handel Eli Lilly (LLY)

Kategoria

Historia ceny akcji dla Eli Lilly (LLY)
Najwyższa cena zamknięcia: $971.65 dnia 2026-03-01

Najniższa cena zamknięcia: $4.11 dnia 1972-06-01
Historia cen akcji firmy Eli Lilly od 1972 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -16.73%
2025 32.00%
2024 36.13%
2023 59.08%
2022 40.15%
2021 62.28%
2020 28.57%
2019 11.15%
2018 30.99%
2017 21.80%
2016 -17.45%
2015 20.78%
2014 40.74%
2013 2.24%
2012 22.60%
2011 15.15%
2010 -3.80%
2009 -0.25%
2008 -32.47%
2007 0.97%
2006 -3.69%
2005 -1.19%
2004 -21.27%
2003 9.52%
2002 -19.84%
2001 -10.68%
2000 33.91%
1999 -22.78%
1998 32.51%
1997 76.25%
1996 43.03%
1995 65.61%
1994 9.23%
1993 -8.66%
1992 -18.33%
1991 3.94%
1990 13.37%
1989 49.66%
1988 22.37%
1987 -4.38%
1986 40.67%
1985 64.99%
1984 11.02%
1983 1.09%
1982 4.83%
1981 -6.12%
1980 -3.35%
1979 32.59%
1978 22.86%
1977 -19.01%
1976 -13.66%
1975 -17.93%
1974 -12.91%
1973 -2.50%
1972 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$184.07 148.44%
GB
$235.42 44.17%
US
$204.93 -2.03%
US
$148.09 33.31%
CH
$115.67 25.31%
US